|
Dr. Atreya Dash joined the Department of Urology at UC Irvine in August 2007 after completing a three-year fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York. He previously completed his urology training at the University of Michigan. Dr. Dash has experience in all areas of urologic oncology such as the surgical treatment of prostate, renal, testis and bladder cancers including the use of continent urinary diversion for reconstruction after cystectomy. He also plans to use new minimally-invasive surgical technologies such as laparoscopy to improve the care of patients with urologic cancers.
Dr. Dash's clinical research has focused on prostate, bladder, kidney and testis cancers. He has authored publications that have been accepted or are forthcoming in peer reviewed journals. His laboratory research has focused on molecular aspects of prostate and bladder cancer including application of microarray technology. This work has also resulted in peer reviewed publications.
In 2002 Dr. Dash was awarded 2nd prize for best article by a trainee by the journal, Urology. More recently, he received a 2007 ASCO Foundation Merit Award for his submission as a fellow to the American Society of Clinical Oncology annual meeting.
He is an active member of the American Urological Association, The Society of Urologic Oncology, and the American Society of Clinical Oncology.
Training
Undergraduate: Williams College
Medical School: University of Vermont
Residency: University of Michigan
Fellowship Training: Memorial Sloan-Kettering Cancer Center |